About
Macrogenics Inc (NASDAQ:MGNX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
Mar 9 2026
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Feb 23 2026
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Nov 25 2025
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
Nov 12 2025
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
Recent Videos

MGNX STOCK : POTENTIAL BOUNCEBACK | MACROGENICS STOCK
Apr 13, 2026

09 April 26. Biotech Stock News. Daily Recap #English #Shorts $XBI #trading #biotechnews #dailynews
Apr 09, 2026

09 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 09, 2026

Comprar acciones de MacroGenics Inc: guía rápida (MGNX)
Mar 23, 2026
Financials
Revenue
$149.5 M
Market Cap
$195.12 M
EPS
-1.18
Translate